Correlation Between Cyclo Therapeutics and INC Research

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cyclo Therapeutics and INC Research at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cyclo Therapeutics and INC Research into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cyclo Therapeutics and INC Research Holdings, you can compare the effects of market volatilities on Cyclo Therapeutics and INC Research and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cyclo Therapeutics with a short position of INC Research. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cyclo Therapeutics and INC Research.

Diversification Opportunities for Cyclo Therapeutics and INC Research

0.47
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Cyclo and INC is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Cyclo Therapeutics and INC Research Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on INC Research Holdings and Cyclo Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cyclo Therapeutics are associated (or correlated) with INC Research. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of INC Research Holdings has no effect on the direction of Cyclo Therapeutics i.e., Cyclo Therapeutics and INC Research go up and down completely randomly.

Pair Corralation between Cyclo Therapeutics and INC Research

Assuming the 90 days horizon Cyclo Therapeutics is expected to under-perform the INC Research. In addition to that, Cyclo Therapeutics is 9.07 times more volatile than INC Research Holdings. It trades about -0.62 of its total potential returns per unit of risk. INC Research Holdings is currently generating about -0.49 per unit of volatility. If you would invest  158.00  in INC Research Holdings on January 12, 2025 and sell it today you would lose (34.00) from holding INC Research Holdings or give up 21.52% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy50.0%
ValuesDaily Returns

Cyclo Therapeutics  vs.  INC Research Holdings

 Performance 
       Timeline  
Cyclo Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Cyclo Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's technical indicators remain fairly stable which may send shares a bit higher in May 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.
INC Research Holdings 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days INC Research Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Even with fragile performance in the last few months, the Stock's fundamental indicators remain relatively invariable which may send shares a bit higher in May 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Cyclo Therapeutics and INC Research Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cyclo Therapeutics and INC Research

The main advantage of trading using opposite Cyclo Therapeutics and INC Research positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cyclo Therapeutics position performs unexpectedly, INC Research can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in INC Research will offset losses from the drop in INC Research's long position.
The idea behind Cyclo Therapeutics and INC Research Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Equity Valuation
Check real value of public entities based on technical and fundamental data
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world